As IL-1β and IL-6 are associated with glioblastoma angiogenesis, we confirmed that KDELC2 suppression could inhibit the expression of some angiogenic factors, such as FGF and VEGF (Figure 5D). This evidence concerns the gene POGLUT3 and glioblastoma.